Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Novartis India Reports 16.6% Profit Increase and 18% Revenue Growth in Q1 2026

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Novartis India Reports 16.6% Profit Increase and 18% Revenue Growth in Q1 2026

Analysed 23 Jul 2026·3 sources analysed·India·Business
Novartis India Reports 16.6% Profit Increase and 18% Revenue Growth in Q1 2026PreviousNext

Novartis India reported a 16.6% rise in standalone net profit to Rs 32.21 crore for the quarter ended June 2026, compared to Rs 27.62 crore a year earlier. Revenue from operations increased by over 18% to approximately Rs 104 crore. Total expenses rose by around 14% year-on-year but declined slightly sequentially. Earnings per share improved to 13.05. The company also noted the impact of new labour codes increasing employee benefit provisions. Despite positive financial results, Novartis India's share price fell about 3% intraday following the announcement.

Sentiment
58%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 38/100.

Outlets measured: thefinancialexpress, businessstandard, freepressjournal. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 23 Jul 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (58/100)

Sentiment was consistent across outlets (55–65/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

freepressjournal broke this story on 23 Jul, 07:45 am. Other outlets followed.

23 Jul, 07:45 am3 sources · 53 min23 Jul, 08:38 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Ujjivan Small Finance Bank Reports Over 200% Net Profit Growth in Q1 FY27
Next →
Indian Railways Develops Kavach 5.0 to Enhance Mumbai Local Train Safety and Capacity
  1. 1
    freepressjournal23 Jul, 07:45 am
    Novartis India Profit Up 16.59 At 32.21 Crore For June Quarter
  2. 2
    businessstandard23 Jul, 08:23 am
    Novartis India standalone net profit rises 16.62 in the June 2026 quarter
  3. 3
    thefinancialexpress23 Jul, 08:38 am
    Novartis India Q1 profit up 16 , revenue climbs 18 ; shares fall 3

Who's involved

Institutions and figures named across source coverage.

Corporate
ChrysCapital Fund XOil Natural Gas Corpn LtdWaveRise Investments LimitedZaggleNovartis India LimitedTwo Infinity PartnersMedPlus Health ServicesAPL Apollo Tubes LtdNovartis IndiaCiplaNovartis AG

Story context

Category
Business
Location
India
Sources analysed
3
Last analysed
23 Jul 2026
Key entities
NovartisCroreIndian rupeeIndiaNet incomeEarnings per shareRevenueMumbaiFiscal yearCommon stockLabour Party (UK)Lakh